Publications

Autophagy Is Required for the Therapeutic Effects of the Nad+ Precursor Nicotinamide in Obesity-Related Heart Failure with Preserved Ejection Fraction

AuthID
P-018-A81

Author(s)

Abdellatif, M

Vasques-Nóvoa, F

Trummer-Herbst, V

Durand, S

Koser, F

Islam, M

Nah, J

Sung, EA

Feng, RL

Aprahamian, F

Prokesch, A

Zardoya-Laguardia, P

Sadoshima, J

Diwan, A

Linke, WA

Ferreira, JP

Kroemer, G

Sedej, S

Document Type

Article in Press

Year published

2025

Published

in EUROPEAN HEART JOURNAL, ISSN: 0195-668X

Volume: 46, Issue: 19, Pages: 1863-1866 (4)

Indexing

Wos^®

Scopus^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1093/eurheartj/ehaf062

Pubmed: 39995248

Scopus: 2-s2.0-105005315102

Wos: WOS:001429367000001

Source Identifiers

ISSN: 0195-668X

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Autophagy Is Required for the Therapeutic Effects of the Nad+ Precursor Nicotinamide in Obesity-Related Heart Failure with Preserved Ejection Fraction

Useful Links

Get Help

Federated Authentication (Click on the image)

Autophagy Is Required for the Therapeutic Effects of the Nad+ Precursor Nicotinamide in Obesity-Related Heart Failure with Preserved Ejection Fraction

Useful Links

Get Help